U.S. markets closed
View all reports

TransCode Therapeutics, Inc. (RNAZ) stock forecast and price target

Find the latest TransCode Therapeutics, Inc. RNAZ analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Date Range
investment rating
report type
sector
industry
provider
RNAZTransCode Therapeutics, Inc.
0.4399-0.0200 (-4.35%)
At close: 08:00PM

Recommendation Rating

2

Analyst Price Targets (1)

Current 0.44
Average 120.00
Low 120.00
High 120.00
Related Research Reports1-1 of 1 results
Report NameSymbolsSectorProviderDate
LXRX,RNAZ,BRT,DFH,SCWX,SJM,LLY,SEIC,EGLE,PEB
Financial Services,Technology,Real Estate,Healthcare,Industrials,Consumer Defensive,Consumer Cyclical
ArgusJun 23, 2023Upgrade to begin downloading full reports